Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 28, 2017
Pharmacy Choice - Pharmaceutical News - Breckenridge Pharmaceutical, Inc. Announces Launch of Desvenlafaxine XR Tablets generic for Pristiq - March 28, 2017

Pharmacy News Article

 3/17/17 - Breckenridge Pharmaceutical, Inc. Announces Launch of Desvenlafaxine XR Tablets generic for Pristiq

By a News Reporter-Staff News Editor at Drug Week - Breckenridge Pharmaceutical, Inc. announced the launch of desvenlafaxine succinate extended-release tablets 50mg and 100mg, a generic version of Pristiq by Pfizer Inc. The ANDA was filed as a Paragraph IV on the first-to-file date and will share 180-day exclusivity with other ANDA first filers. Alembic Pharmaceuticals Limited is the manufacturer of the ANDA, which will be marketed exclusively by Breckenridge. The Paragraph IV litigation was settled on terms that are confidential.

Desvenlafaxine is a prescription drug that is indicated for the treatment of major depressive disorder, and is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). Pristiq generated sales of $883 million, based on December, 2016 IMS Health Sales Data.

Breckenridge's litigation involving desvenlafaxine succinate extended-release tablets 50mg and 100mg highlights its aggressive Paragraph IV strategy. Breckenridge currently has twenty-seven (27) ANDAs filed and pending with FDA that contain Paragraph IV patent challenges, and intends to continue that trend in the next several years, focusing on niche and first-to-file Paragraph IV opportunities with certain barriers to entry.

Keywords for this news article include: Antidepressants, Breckenridge Pharmaceutical Inc., Desvenlafaxine, Drugs and Therapies, Psychotherapeutic Agents, Serotonin-Norepinephrine Reuptake Inhibitors (see also Breckenridge Pharmaceutical, Inc.).

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC



(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Mar 28: Adverse Drug Events: Risk Reduction and Reporting
Mar 30: Know Your Value, Know Your Worth: Provider Status in Pharmacy
Mar 31: Medication Safety & Drug Safety Alerts
Apr 03: Headache Disorders: Focus on Migraines & Tension Headaches
Apr 04: Medication Therapy Management and Beyond: Implications for Pharmacists
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415